Related Experiment Video
Updated: Apr 27, 2026

Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches
Published on: September 5, 2025
Perivascular adipose tissue, potassium channels, and vascular dysfunction.
Jean-Yves Tano1, Johanna Schleifenbaum2, Maik Gollasch2
1From the Experimental and Clinical Research Center, Berlin-Buch, Germany; and Nephrology/Intensive Care Section, Charité Campus Virchow, Berlin, Germany. maik.gollasch@charite.de.
Perivascular adipose tissue releases adipose-derived relaxing factor (ADRF), a potassium channel opener. ADRF plays a key role in vascular dysfunction associated with obesity and hypertension, offering potential therapeutic targets for cardiovascular disease.
Area of Science:
- Cardiovascular Biology
- Metabolic Disease Research
- Adipose Tissue Physiology
Background:
- Perivascular adipose tissue (PVAT) significantly impacts cardiovascular and metabolic disease pathology.
- PVAT influences vascular regulation and myogenic response through adipokines and other factors.
- Discovery of PVAT's vasodilatory properties led to the identification of adipose-derived relaxing factor (ADRF).
Purpose of the Study:
- To review the role of ADRF in vascular dysfunction in obesity and hypertension.
- To discuss potassium channels modulated by ADRF.
- To explore pharmacological agents mimicking ADRF for cardiovascular disease treatment.
Main Methods:
- Literature review on PVAT, ADRF, and vascular function.
- Analysis of studies investigating ADRF's mechanism of action on potassium channels.
- Examination of pharmacological strategies targeting ADRF pathways.
Main Results:
- ADRF acts as a paracrine smooth muscle cell potassium channel opener.
- ADRF is implicated in mitigating vascular dysfunction in obesity and hypertension.
- Specific potassium channels activated by ADRF are identified.
Conclusions:
- ADRF is a crucial factor in vascular health, particularly in metabolic and cardiovascular diseases.
- Targeting ADRF or its downstream effectors presents a promising therapeutic avenue.
- Pharmacological mimetics of ADRF could offer novel treatments for vascular dysfunction.
More Related Videos
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
06:56Author Spotlight: The Significance of Isolation, Culture, and Adipogenic Induction of SVF-Derived Preadipocytes from Mouse Perivascular Adipose Tissue
Published on: July 21, 2023
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
Peripheral Artery Disease I: Introduction
Cytotoxic Edema: Pathophysiology
Hypertension II: Pathophysiology
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers